September 2024
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Positive

Pavlos Msaouel: The second Msaouel Lab R01 proposal has been funded to investigate Renal Medullary Carcinoma

Photo from Pavlos Msaouel/X

Aug 12, 2024, 13:28

Pavlos Msaouel: The second Msaouel Lab R01 proposal has been funded to investigate Renal Medullary Carcinoma

Pavlos Msaouel, Physician-Scientist at Msaouel Lab, shared on X:

“The second Msaouel Lab R01 proposal has now been funded to investigate Renal Medullary Carcinoma as a model to understand and target key cancer hallmarks.

This one is a multiPI collaborative effort with each team synergizing to identify unifying principles.”

Pavlos Msaouel

Petros Grivas sent his congratulations:

“Congratulations Pavlos Msaouel and team! This is truly fantastic and so well deserved!”

Mohammad Jad Moussa, GU Oncology fellow at MD Anderson Cancer Center, also shared a post on X, congratulating Pavlos Msaouel:

“Congratulations, Dr. Pavlos Msaouel, on your achievements. We keep learning from your Medical Science, Data Science expertise, passion, and, most importantly, your humility. Together in this fight against rare GU tumors!“

Source: Pavlos Msaouel/X, Petros Grivas/X and Mohammad Jad Moussa/X

Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.